Bloxiverz is one of 3 small molecule programs targeting Snoring. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Applications
NDA/BLA/ANDA regulatory filings
Pipeline
Competition
4 competitors in Snoring
Bloxiverz
XEOMIN
Pulmicort
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Regulatory
May 31, 2013
BLOXIVERZ
NDA NDA204078
Sep 18, 2018
NEOSTIGMINE METHYLSULFATE
NDA NDA203629
Sources
Details